In Reply

J Thorac Oncol. 2018 May;13(5):e86-e87. doi: 10.1016/j.jtho.2018.02.003.

Authors

Junko Tanizaki¹, Yasutaka Chiba², Koji Haratani¹, Hidetoshi Hayashi³, Kazuhiko Nakagawa¹

Affiliations

¹ Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan.
² Clinical Research Center, Kindai University Hospital, Osaka-Sayama, Japan.
³ Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan. Electronic address: hidet31@med.kindai.ac.jp.

PMID: 29703548
DOI: 10.1016/j.jtho.2018.02.003

No abstract available

Publication types

Letter
Comment

MeSH terms

Biomarkers
Carcinoma, Non-Small-Cell Lung*
Humans
Lung Neoplasms*
Nivolumab

Substances

Biomarkers
Nivolumab